Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The investigators encourage radiologists to consider the numbers and take steps to “reinforce their gatekeeper function” to help cut ultrasound overutilization.
The owner of a portable x-ray business faces serious jail time for attempting to defraud Medicare and Medicaid of $3.7 million, forging signatures and making false statements to hide his tracks.
Two-thirds of U.S. adults eligible to get screened for colorectal cancer have recently completed an exam, but only 1.4% of them opted for CT colonography over optical colonoscopy or sigmoidoscopy.
AB-MRI is a cost-effective means of screening women with dense breast tissue for breast cancer—as long as the per-exam costs don’t top 82% of what would have been spent to perform full-protocol breast MRI.
Sant’Andrea University Hospital in Rome saw overall imaging volumes plummet 21.5% but improved numbers among vulnerable populations using real-time data, experts wrote in European Radiology.
Analysts highlighted the imaging giant's “strong” competitive position, multifaceted revenue streams through the delivery of various imaging modalities, and payer diversity.